PD-L1, KIM-1 Levels May Predict Kidney Cancer Response to Opdivo, Yervoy
PD-L1 expression levels were found to predict improved outcomes with Opdivo and Yervoy in patients with ccRCC, while high KIM-1 ...
Tag: nivolumab
Perioperative Opdivo Extends Event-Free Survival in Lung Cancer
Patients with resectable (surgically unremovable) non-small cell lung cancer (NSCLC) undergoing treatment with perioperative Opdivo (nivolumab) demonstrated extended event-free survival ...